Tolvaptan treatment improves survival of cirrhotic patients with ascites and hyponatremia

Abstract Background Although tolvaptan treatment improves hyponatremia, only few studies have investigated whether tolvaptan actually benefits the survival of cirrhotic patients. This study evaluated the impact of tolvaptan on six-month survival of decompensated cirrhotic patients with and without h...

Full description

Bibliographic Details
Published in:BMC Gastroenterology
Main Authors: Shuzhen Wang, Xin Zhang, Tao Han, Wen Xie, Yonggang Li, Hong Ma, Roman Liebe, Honglei Weng, Hui-Guo Ding
Format: Article
Language:English
Published: BMC 2018-09-01
Subjects:
Ascites
Hyponatremia
Liver cirrhosis
Survival
Tolvaptan
Online Access:http://link.springer.com/article/10.1186/s12876-018-0857-0

Internet

http://link.springer.com/article/10.1186/s12876-018-0857-0

Similar Items